Metin Kurtoglu, Chief Technology Officer at Cartesian Therapeutics, Inc. (RNAC), sold 4,875 shares at $16.72 ($82K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $82k RNAC by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.72 | 2,417 | $40K | 49.4% |
| 2 | $16.83 | 2,458 | $41K | 50.6% |
| Total | $16.78 avg | 4,875 | $82K | 100% |
| Filing → |
| RNAC | SELL | 2024-11-18 | $2.8M | — | Filing → |